{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:53:58Z","timestamp":1785333238899,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF17SA0031406"],"award-info":[{"award-number":["NNF17SA0031406"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009857","name":"Regeneron","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sanofi-Genzyme"},{"name":"Eli Lilly"},{"name":"Novartis"},{"name":"Bristol-Myers Squibb"},{"name":"AbbVie"},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Boehringer Ingelheim"},{"name":"Danish National Psoriasis Foundation"},{"DOI":"10.13039\/501100014553","name":"Simon Spies Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014553","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006286","name":"Kongelig Hofbuntmager Aage Bangs Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006286","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Studies examining the association between type 1 diabetes (T1D) and atopic diseases, i.e., atopic dermatitis, allergic rhinitis and asthma have yielded conflicting results due to different algorithms for classification, sample size issues and risk of referral bias of exposed cohorts with frequent contact to health care professionals. Using Danish national registries and well-established disease algorithms, we examined the bidirectional association between T1D and atopic diseases in childhood and adolescence using Cox Proportional Hazard regression compared to two different unexposed cohorts from a population of 1.5 million Danish children born from 1997 to 2018. We found no associations between T1D and atopic dermatitis, allergic rhinitis, or asthma (defined after age five). However, in multivariable analysis we found an increased risk of persistent wheezing (defined as asthma medication before age five) after T1D with an adjusted hazard ratio (aHR) of 1.70 [1.17\u20132.45]. We also identified an increased risk of developing T1D after persistent wheezing with aHR of 1.24 [1.13\u20131.36]. This study highlights similar risks of atopic diseases in children with T1D and of T1D in children with atopic disease after age of five years versus healthy controls. However, more research is needed to understand the possible early immunological effects of the link between persistent wheezing and T1D.<\/jats:p>","DOI":"10.1038\/s41598-023-47292-5","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T06:02:42Z","timestamp":1700028162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["No associations between type 1 diabetes and atopic dermatitis, allergic rhinitis, or asthma in childhood: a nationwide Danish case-cohort study"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1260-0615","authenticated-orcid":false,"given":"Anna Korsgaard","family":"Berg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9365-0728","authenticated-orcid":false,"given":"Jannet","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3770-1743","authenticated-orcid":false,"given":"Jacob P.","family":"Thyssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6846-6243","authenticated-orcid":false,"given":"Bo","family":"Chawes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5506-1319","authenticated-orcid":false,"given":"Claus","family":"Zachariae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8257-1816","authenticated-orcid":false,"given":"Alexander","family":"Egeberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4783-2931","authenticated-orcid":false,"given":"Steffen Ullitz","family":"Thorsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,15]]},"reference":[{"issue":"Suppl 27","key":"47292_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/pedi.12734","volume":"19","author":"JJ Couper","year":"2018","unstructured":"Couper, J. J. et al. ISPAD Clinical Practice Consensus Guidelines 2018: Stages of type 1 diabetes in children and adolescents. Pediatr. Diabetes 19(Suppl 27), 20\u201327 (2018).","journal-title":"Pediatr. Diabetes"},{"key":"47292_CR2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.34172\/hpp.2020.18","volume":"10","author":"M Mobasseri","year":"2020","unstructured":"Mobasseri, M. et al. Prevalence and incidence of type 1 diabetes in the world: A systematic review and meta-analysis. Health Promot. Perspect. 10, 98\u2013115 (2020).","journal-title":"Health Promot. Perspect."},{"key":"47292_CR3","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S2213-8587(22)00218-2","volume":"10","author":"GA Gregory","year":"2022","unstructured":"Gregory, G. A. et al. Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: A modelling study. Lancet Diabetes Endocrinol. 10, 741\u2013760 (2022).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"47292_CR4","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1111\/j.1398-9995.1998.tb03810.x","volume":"53","author":"G Lilja","year":"1998","unstructured":"Lilja, G. & Wickman, M. Allergy-atopy-hypersensitivity\u2014A matter of definition. Allergy 53, 1011\u20131012 (1998).","journal-title":"Allergy"},{"key":"47292_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/BF02786470","volume":"20","author":"VK Singh","year":"1999","unstructured":"Singh, V. K., Mehrotra, S. & Agarwal, S. S. The paradigm of Th1 and Th2 cytokines: Its relevance to autoimmunity and allergy. Immunol. Res. 20, 147\u2013161 (1999).","journal-title":"Immunol. Res."},{"key":"47292_CR6","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0140-6736(00)04067-8","volume":"357","author":"LC Stene","year":"2001","unstructured":"Stene, L. C. & Nafstad, P. Relation between occurrence of type 1 diabetes and asthma. Lancet 357, 607\u2013608 (2001).","journal-title":"Lancet"},{"key":"47292_CR7","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1136\/annrheumdis-2022-222460","volume":"81","author":"Y Shirai","year":"2022","unstructured":"Shirai, Y. et al. Multi-trait and cross-population genome-wide association studies across autoimmune and allergic diseases identify shared and distinct genetic component. Ann. Rheum. Dis. 81, 1301\u20131312 (2022).","journal-title":"Ann. Rheum. Dis."},{"key":"47292_CR8","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.2337\/diacare.26.9.2568","volume":"26","author":"CR Cardwell","year":"2003","unstructured":"Cardwell, C. R., Shields, M. D., Carson, D. J. & Patterson, C. C. A meta-analysis of the association between childhood Type 1 diabetes and atopic disease. Diabetes Care 26, 2568\u20132574 (2003).","journal-title":"Diabetes Care"},{"key":"47292_CR9","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/ije\/dyx245","volume":"47","author":"J Mets\u00e4l\u00e4","year":"2018","unstructured":"Mets\u00e4l\u00e4, J. et al. The association between asthma and type 1 diabetes: A paediatric case-cohort study in Finland, years 1981\u20132009. Int. J. Epidemiol. 47, 409\u2013416 (2018).","journal-title":"Int. J. Epidemiol."},{"key":"47292_CR10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/bjd.14166","volume":"174","author":"C-H Lin","year":"2016","unstructured":"Lin, C.-H., Wei, C.-C., Lin, C.-L., Lin, W.-C. & Kao, C.-H. Childhood type 1 diabetes may increase the risk of atopic dermatitis. Br. J. Dermatol. 174, 88\u201394 (2016).","journal-title":"Br. J. Dermatol."},{"key":"47292_CR11","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s12020-021-02973-x","volume":"75","author":"R Zeng","year":"2022","unstructured":"Zeng, R. et al. Type 1 diabetes and asthma: A systematic review and meta-analysis of observational studies. Endocrine 75, 709\u2013717 (2022).","journal-title":"Endocrine"},{"key":"47292_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/1403494811401482","volume":"39","author":"E Lynge","year":"2011","unstructured":"Lynge, E., Sandegaard, J. L. & Rebolj, M. The Danish National Patient Register. Scand. J. Public Health 39, 30\u201333 (2011).","journal-title":"Scand. J. Public Health"},{"key":"47292_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/1403494810394717","volume":"39","author":"HW Kildemoes","year":"2011","unstructured":"Kildemoes, H. W., S\u00f8rensen, H. T. & Hallas, J. The Danish National Prescription Registry. Scand. J. Public Health 39, 38\u201341 (2011).","journal-title":"Scand. J. Public Health"},{"key":"47292_CR14","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1111\/pedi.13453","volume":"23","author":"KL Ode","year":"2022","unstructured":"Ode, K. L. et al. ISPAD Clinical Practice Consensus Guidelines 2022: Management of cystic fibrosis-related diabetes in children and adolescents. Pediatr. Diabetes 23, 1212\u20131228 (2022).","journal-title":"Pediatr. Diabetes"},{"key":"47292_CR15","first-page":"122","volume":"169","author":"J Svensson","year":"2007","unstructured":"Svensson, J., Marinelli, K. & Eising, S. Danish Childhood Diabetes Register, & National Discharge Register [Comparison of registration of data from the Danish Childhood Diabetes Register and The National Discharge Register]. Ugeskr. Laeger 169, 122\u2013125 (2007).","journal-title":"Ugeskr. Laeger"},{"key":"47292_CR16","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1111\/jdv.15424","volume":"33","author":"YMF Andersen","year":"2019","unstructured":"Andersen, Y. M. F., Egeberg, A., Skov, L. & Thyssen, J. P. Demographics, healthcare utilization and drug use in children and adults with atopic dermatitis in Denmark: a population-based cross-sectional study. J. Eur. Acad. Dermatol. Venereol. JEADV 33, 1133\u20131142 (2019).","journal-title":"J. Eur. Acad. Dermatol. Venereol. JEADV"},{"key":"47292_CR17","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1002\/pds.5120","volume":"29","author":"KB Leth-M\u00f8ller","year":"2020","unstructured":"Leth-M\u00f8ller, K. B., Skaaby, T., Madsen, F., Petersen, J. & Linneberg, A. Can we identify allergic rhinitis from administrative data: A validation study. Pharmacoepidemiol. Drug Saf. 29, 1423\u20131431 (2020).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"47292_CR18","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jaci.2015.02.003","volume":"136","author":"L Henriksen","year":"2015","unstructured":"Henriksen, L. et al. Incidence rates of atopic dermatitis, asthma, and allergic rhinoconjunctivitis in Danish and Swedish children. J. Allergy Clin. Immunol. 136, 360-366.e2 (2015).","journal-title":"J. Allergy Clin. Immunol."},{"key":"47292_CR19","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/pai.12743","volume":"28","author":"LG Stensballe","year":"2017","unstructured":"Stensballe, L. G. et al. The validity of register data to identify children with atopic dermatitis, asthma or allergic rhinoconjunctivitis. Pediatr. Allergy Immunol. 28, 535\u2013542 (2017).","journal-title":"Pediatr. Allergy Immunol."},{"key":"47292_CR20","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1111\/j.1365-2222.2009.03321.x","volume":"39","author":"FE Hargreave","year":"2009","unstructured":"Hargreave, F. E. & Nair, P. The definition and diagnosis of Asthma. Clin. Exp. Allergy 39, 1652\u20131658 (2009).","journal-title":"Clin. Exp. Allergy"},{"key":"47292_CR21","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1111\/j.1651-2227.2007.00460.x","volume":"96","author":"G Moth","year":"2007","unstructured":"Moth, G., Vedsted, P. & Schi\u00f8tz, P. National registry diagnoses agree with medical records on hospitalized asthmatic children. Acta Paediatr. 96, 1470\u20131473 (2007).","journal-title":"Acta Paediatr."},{"key":"47292_CR22","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00228-007-0286-4","volume":"63","author":"G Moth","year":"2007","unstructured":"Moth, G., Vedsted, P. & Schi\u00f8tz, P. Identification of asthmatic children using prescription data and diagnosis. Eur. J. Clin. Pharmacol. 63, 605\u2013611 (2007).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"47292_CR23","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1001\/jama.2011.822","volume":"305","author":"ER Haut","year":"2011","unstructured":"Haut, E. R. & Pronovost, P. J. Surveillance bias in outcomes reporting. JAMA 305, 2462\u20132463 (2011).","journal-title":"JAMA"},{"key":"47292_CR24","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s10654-013-9873-0","volume":"29","author":"LC Thygesen","year":"2014","unstructured":"Thygesen, L. C. & Ersb\u00f8ll, A. K. When the entire population is the sample: Strengths and limitations in register-based epidemiology. Eur. J. Epidemiol. 29, 551\u2013558 (2014).","journal-title":"Eur. J. Epidemiol."},{"key":"47292_CR25","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA 310, 2191\u20132194 (2013).","journal-title":"JAMA"},{"key":"47292_CR26","doi-asserted-by":"crossref","unstructured":"Ahmadizar, F., Souverein, P. C., Arets, H. G. M., Boer, A. de & Zee, A. H. M. der. Asthma related medication use and exacerbations in children and adolescents with type 1 diabetes. Pediatr. Pulmonol. 51, 1113\u20131121 (2016).","DOI":"10.1002\/ppul.23428"},{"key":"47292_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1365-2249.2008.03679.x","volume":"153","author":"RL Rabin","year":"2008","unstructured":"Rabin, R. L. & Levinson, A. I. The nexus between atopic disease and autoimmunity: A review of the epidemiological and mechanistic literature. Clin. Exp. Immunol. 153, 19\u201330 (2008).","journal-title":"Clin. Exp. Immunol."},{"key":"47292_CR28","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.ecl.2020.07.003","volume":"49","author":"DB Allen","year":"2020","unstructured":"Allen, D. B. Inhaled corticosteroids and endocrine effects in childhood. Endocrinol. Metab. Clin. North Am. 49, 651\u2013665 (2020).","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"47292_CR29","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/pedi.13454","volume":"23","author":"I Libman","year":"2022","unstructured":"Libman, I. et al. ISPAD Clinical Practice Consensus Guidelines 2022: Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr. Diabetes 23, 1160\u20131174 (2022).","journal-title":"Pediatr. Diabetes"},{"key":"47292_CR30","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/dmrr.2486","volume":"30","author":"JL Hwang","year":"2014","unstructured":"Hwang, J. L. & Weiss, R. E. Steroid-induced diabetes: A clinical and molecular approach to understanding and treatment. Diabetes Metab. Res. Rev. 30, 96\u2013102 (2014).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"47292_CR31","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1164\/rccm.200702-212OC","volume":"176","author":"S Saglani","year":"2007","unstructured":"Saglani, S. et al. Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers. Am. J. Respir. Crit. Care Med. 176, 858\u2013864 (2007).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"47292_CR32","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.2147\/NDT.S235165","volume":"16","author":"M Sadowska","year":"2020","unstructured":"Sadowska, M., Sarecka-Hujar, B. & Kopyta, I. Cerebral palsy: Current opinions on definition, epidemiology, risk factors, classification and treatment options. Neuropsychiatr. Dis. Treat. 16, 1505\u20131518 (2020).","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"47292_CR33","doi-asserted-by":"publisher","first-page":"5757","DOI":"10.3390\/ijms22115757","volume":"22","author":"L Sgrazzutti","year":"2021","unstructured":"Sgrazzutti, L., Sansone, F., Attanasi, M., Di Pillo, S. & Chiarelli, F. Coaggregation of asthma and Type 1 diabetes in children: A narrative review. Int. J. Mol. Sci. 22, 5757 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"47292_CR34","doi-asserted-by":"publisher","first-page":"e13858","DOI":"10.1111\/pai.13858","volume":"33","author":"J Xie","year":"2022","unstructured":"Xie, J. et al. Childhood asthma and type 1 diabetes mellitus: A meta-analysis and bidirectional Mendelian randomization study. Pediatr. Allergy Immunol. 33, e13858 (2022).","journal-title":"Pediatr. Allergy Immunol."},{"key":"47292_CR35","doi-asserted-by":"crossref","unstructured":"Smew, A. I., Lundholm, C., S\u00e4vendahl, L., Lichtenstein, P. & Almqvist, C. Familial Coaggregation of Asthma and Type 1 Diabetes in Children. JAMA Netw. Open 3, (2020).","DOI":"10.1183\/13993003.congress-2020.1214"},{"key":"47292_CR36","doi-asserted-by":"publisher","first-page":"21728","DOI":"10.1038\/s41598-022-26067-4","volume":"12","author":"MS Liljendahl","year":"2022","unstructured":"Liljendahl, M. S. et al. Childhood asthma is associated with development of type 1 diabetes and inflammatory bowel diseases: A Danish nationwide registry study. Sci. Rep. 12, 21728 (2022).","journal-title":"Sci. Rep."},{"key":"47292_CR37","doi-asserted-by":"crossref","unstructured":"Hsiao, Y.-T. et al. Type 1 diabetes and increased risk of subsequent asthma. Medicine (Baltimore) 94, (2015).","DOI":"10.1097\/MD.0000000000001466"},{"key":"47292_CR38","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1093\/aje\/kwx083","volume":"185","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele, T. J. Invited commentary: The continuing need for the sufficient cause model today. Am. J. Epidemiol. 185, 1041\u20131043 (2017).","journal-title":"Am. J. Epidemiol."},{"key":"47292_CR39","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1007\/s00125-009-1427-3","volume":"52","author":"K Hemminki","year":"2009","unstructured":"Hemminki, K., Li, X., Sundquist, J. & Sundquist, K. Familial association between type 1 diabetes and other autoimmune and related diseases. Diabetol. Heidelb. 52, 1820\u20131828 (2009).","journal-title":"Diabetol. Heidelb."},{"key":"47292_CR40","doi-asserted-by":"crossref","unstructured":"Munyaka, P. M., Khafipour, E. & Ghia, J.-E. External influence of early childhood establishment of gut microbiota and subsequent health implications. Front. Pediatr. 2, (2014).","DOI":"10.3389\/fped.2014.00109"},{"key":"47292_CR41","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.cyto.2006.04.015","volume":"34","author":"E Kainonen","year":"2006","unstructured":"Kainonen, E., Rautava, S., Korkeam\u00e4ki, M. & Isolauri, E. Unique cytokine secretion profile in children with both type I diabetes and asthma distinct from that of solely diabetic or asthmatic children. Cytokine 34, 198\u2013205 (2006).","journal-title":"Cytokine"},{"key":"47292_CR42","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1586\/1744666X.4.6.767","volume":"4","author":"A Tedeschi","year":"2008","unstructured":"Tedeschi, A. & Asero, R. Asthma and autoimmunity: A complex but intriguing relation. Expert Rev. Clin. Immunol. Lond. 4, 767\u2013776 (2008).","journal-title":"Expert Rev. Clin. Immunol. Lond."},{"key":"47292_CR43","doi-asserted-by":"publisher","first-page":"e1001748","DOI":"10.1371\/journal.pmed.1001748","volume":"11","author":"DCM Belgrave","year":"2014","unstructured":"Belgrave, D. C. M. et al. Developmental profiles of eczema, wheeze, and rhinitis: Two population-based birth cohort studies. PLoS Med. 11, e1001748 (2014).","journal-title":"PLoS Med."},{"key":"47292_CR44","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/CLEP.S91125","volume":"7","author":"M Schmidt","year":"2015","unstructured":"Schmidt, M. et al. The Danish National Patient Registry: A review of content, data quality, and research potential. Clin. Epidemiol. 7, 449\u2013490 (2015).","journal-title":"Clin. Epidemiol."},{"key":"47292_CR45","first-page":"798","volume":"46","author":"A Potteg\u00e5rd","year":"2017","unstructured":"Potteg\u00e5rd, A. et al. Data resource profile: The Danish National Prescription Registry. Int. J. Epidemiol. 46, 798\u2013798f (2017).","journal-title":"Int. J. Epidemiol."},{"key":"47292_CR46","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/jama.2014.9440","volume":"312","author":"J Cao","year":"2014","unstructured":"Cao, J. & Zhang, S. Multiple comparison procedures. JAMA 312, 543\u2013544 (2014).","journal-title":"JAMA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47292-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47292-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47292-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T06:07:52Z","timestamp":1700028472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47292-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,15]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["47292"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-47292-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2561050\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,15]]},"assertion":[{"value":"7 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.K.B, J.S, B.C, C.Z and S.U.T. declare no competing interests for this manuscript.  J.P.T is an advisor for AbbVie, Almirall, Arena Pharmaceuticals, Coloplast, OM Pharma, Aslan Phar-maceuticals, Union Therapeutics, Eli Lilly & Co, LEO Pharma, Pfizer, Regeneron, and Sanofi-Genzyme, a speaker for AbbVie, Almirall, Eli Lilly & Co, LEO Pharma, Pfizer, Regeneron, and Sano-fi-Genzyme, and received research grants from Pfizer, Regeneron, and Sanofi-Genzyme.  A.E has received research funding from Pfizer, Eli Lilly, Novartis, Bristol-Myers Squibb, AbbVie, Janssen Pharmaceuticals, Boehringer Ingelheim, the Danish National Psoriasis Foundation, the Simon Spies Foundation, and the Kgl Hofbundtmager Aage Bang Foundation, and honoraria as consultant and\/or speaker from Amgen, AbbVie, Almirall, Leo Pharma, Zuellig Pharma Ltd., Gal\u00e1pagos NV, Sun Pharmaceuticals, Samsung Bioepis Co., Ltd., Pfizer, Eli Lilly and Company, Novartis, Union Thera-peutics, Galderma, Dermavant, UCB, Mylan, Bristol-Myers Squibb, McNeil Consumer Healthcare, Horizon Therapeutics, Boehringer Ingelheim, and Janssen Pharmaceuticals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19933"}}